This site is intended for healthcare professionals only
LoginRegister
JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterationsJohnson and Johnson Gets CDSCO Panel nod for Additional Indication of Ustekinumab solution for...
Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancerEMA Committee recommends EU label update for Roche Phesgo to allow administration outside of...
Bayer gets UK nod for Lynkuet for moderate to severe vasomotor symptoms associated with menopauseBayer begins Phase I study targeting GPC3 with alpha radiopharmaceutical in advanced hepatocellular...
AstraZeneca Pharma India receives CDSCO nod for expanded use of Imfinzi in bladder cancerAstraZeneca Breztri met primary endpoints in Phase III trials in asthma
Not a Nice Time For Nimesulide? DTAB, CDSCO Recommend Stringent RestrictionsNot a Nice Time For Nimesulide? DTAB, CDSCO Recommend Stringent Restrictions
Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, EuropeCDSCO Panel Approves Dr Reddy's Laboratories Protocol Amendment Proposal to study Abatacept
CDSCO Panel Asks Novartis to Submit Revised Protocol, Dose Changes for Ianalumab Phase III TrialCDSCO Panel Approves Novartis Healthcare's Protocol Amendment to study Iptacopan
Rajasthan govt set to revive Rajasthan Drugs and PharmaRajasthan govt set to revive Rajasthan Drugs and Pharma
JnJ seeks expanded USFDA nod for Caplyta for prevention of relapse in schizophreniaNovo Nordisk application for oral Wegovy accepted by USFDA for weight loss
GSK Pharma names Sukanya Choudhury as Regulatory Head, Growth Emerging MarketsGSK Pharma names Sukanya Choudhury as Regulatory Head, Growth Emerging Markets
Sanofi RiliprubartSanofi Consumer Healthcare India Q1 results PAT up 12.9%
CDSCO Panel nod to MSN Labs Tolvaptan TabletsMSN Laboratories Gets CDSCO Panel Nod To study Brexpiprazole Tablets
X